Career history of Jon Davies
Former positions of Jon Davies
Companies | Position | Start | End |
---|---|---|---|
HORIZON DISCOVERY GROUP PLC | Investor Relations Contact | 2019-03-31 | 2021-08-31 |
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Investor Relations Contact | - | - |
Public Communications Contact | - | - | |
DATATEC LIMITED | Investor Relations Contact | - | - |
Public Communications Contact | - | - | |
TOUCHSTONE INNOVATIONS PLC | Investor Relations Contact | 2013-12-31 | - |
Public Communications Contact | 2013-12-31 | - |
Training of Jon Davies
University of Sussex | Doctorate Degree |
University of London | Undergraduate Degree |
Statistics
International
United Kingdom | 6 |
South Africa | 2 |
Operational
Investor Relations Contact | 4 |
Public Communications Contact | 3 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Finance | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
DATATEC LIMITED | Technology Services |
Private companies | 3 |
---|---|
Touchstone Innovations Ltd.
Touchstone Innovations Ltd. Investment ManagersFinance Touchstone Innovations Ltd. engages in the provision of technology and commercialization services. The company was founded by Susan Jane Searle in 1986 and is headquartered in London, the United Kingdom. | Finance |
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
Horizon Discovery Group Ltd.
Horizon Discovery Group Ltd. Medical SpecialtiesHealth Technology Horizon Discovery Group Ltd. is a cell engineering company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research & Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research & Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in July 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Jon Davies
- Experience